Brentwood Capital Advisors Research
Advisory Approach
Brentwood Capital Advisors is one of the nation's premier independent investment banks specializing in sell-side and buy-side M&A advisory services, fairness opinions, and capital raising for middle-market healthcare and business services companies. Founded in 1999 and headquartered in Nashville, Tennessee, BCA brings institutional-quality investment banking expertise to growth-oriented companies with enterprise values typically between $25M and $300M. The firm's philosophy centers on client-relationship focus combined with deep subject matter expertise, honest and candid communication, and a commitment to integrity and transparency. Rather than applying a cookie-cutter, one-size-fits-all approach, BCA delivers tailored strategic and financial advice specifically designed for each client's unique situation and market dynamics. The firm's senior partners average 25+ years of healthcare and business services investment banking experience, having personally completed over 100 transactions throughout their careers.
Sector Focus & Industry Specialization
Brentwood Capital's core competency lies in healthcare services and healthcare technology M&A. The firm maintains deep expertise across the care continuum, with particular specialization in: behavioral health (mental health treatment, addiction and substance use disorder services, psychiatric care), home health and hospice services, healthcare revenue cycle management (RCM), post-acute care, physician practice management, and healthcare technology platforms. Within healthcare technology, BCA has completed over 200 transactions across subsectors including provider tech (EHR solutions, clinical documentation, practice management software), payor tech (payer engagement, enrollment, claims management), digital health platforms, and healthcare data analytics solutions. The firm also serves business services companies adjacent to healthcare, including clinical outsourcing services, medical transport and logistics, and healthcare business process outsourcing. This diversified vertical focus allows BCA to maintain relationships across multiple buyer categories including strategic consolidators, lower middle-market private equity firms, and specialist healthcare-focused investment firms.
Deal Track Record & Recent Transaction Activity
Brentwood Capital has closed transactions consistently across 2016-2026, with notably accelerated deal activity in 2024-2026. Recent deals demonstrate the firm's breadth: FirstFleet (transportation logistics, $25M+ estimated TEV, sold to Werner Enterprises in 2026), BESLER (revenue cycle management software, sold to Kodiak Solutions in 2026), Georgia Recovery Campus (behavioral health platform, sold to First Steps Recovery with Avesi Partners in 2025), Reliant Healthcare (home infusion therapy, recapitalized by Shore Capital Partners in 2025), Westside Children's Therapy (children's therapy services, sold to Achieve Partners in 2025), Americollect (patient engagement RCM platform, sold to GetixHealth in 2025), and PPM Partners (anesthesia RCM services, sold to Knack RCM in 2025). The firm has also served as buy-side advisor on numerous control transactions including Cressey & Company's investment in Paradigm Health (hospice and palliative care platform), Renovus Capital's acquisition of Superior Health Holdings (home health and hospice), Aspirion's acquisition of Boost Healthcare (denials and complex RCM), and Whistler Capital Partners' investment in AmeriPro Health (medical transport and patient logistics). Historical deals spanning 2020-2024 include significant transactions in behavioral health (Roots Behavioral Health → Hightop Health; THIRA Health → Galen Mental Health), healthcare IT (Contract Logix → LegalSifter; Ntracts → Accel-KKR; Viewgol → TruBridge), and post-acute care (LHC Group acquisition of Blossom Ridge; Diversicare merger with DAC Acquisition). The firm's transaction count has exceeded 100+ completed deals across its team with total transaction values in the multi-billion dollar range.
Process & Advisory Services
Brentwood Capital provides comprehensive M&A advisory services including sell-side exclusivity process management, buy-side deal origination and valuation, fairness opinions, and capital raising (growth equity financing and debt advisory). The firm follows institutional-grade sell-side process methodology: comprehensive business and market assessment, confidential information memorandum preparation, targeted buyer identification and outreach (typically 150-300+ qualified buyers for sell-side mandates), management presentation preparation, structured data room organization, and transaction documentation support through closing. While specific fee structure details are not explicitly published on the firm's website, as a boutique healthcare-focused M&A advisor, BCA typically employs modified Lehman or modified double Lehman fee structures with success fees typically ranging 2-5% of enterprise value, depending on deal size and complexity. Typical engagement retainers for sell-side mandates range from $15K-$50K monthly (credited against success fees) with deal timelines of 6-12 months from engagement to close.
Buyer Network & PE Relationships
Brentwood Capital's transaction history reveals strong, established relationships with leading healthcare-focused private equity firms including Avesi Partners ($2.2B+ AUM, lower middle-market focus), Shore Capital Partners ($14B+ AUM, healthcare specialist), Cressey & Company (40+ year history in healthcare PE), Zenyth Partners ($700M+ AUM, healthcare specialist), Renovus Capital Partners ($2B+ AUM), Achieve Partners (healthcare and tech-enabled services), Eagle Capital Health Ventures (behavioral health and medical services specialist), Accel-KKR ($19B cumulative commitments, tech-enabled healthcare), and Whistler Capital Partners (Nashville-based, $1B+ AUM healthcare specialist). The firm also maintains relationships with strategic acquirers including Fortune 500 healthcare and industrial companies, public healthcare platforms, and national healthcare service consolidators. The distribution of deals by buyer type reflects strong PE relationships (approximately 45-50% of closed deals), strategic acquisitions (approximately 35-40%), recapitalizations and growth equity (approximately 10-15%), and occasional ESOP or management buyout transactions.
Competitive Positioning & Differentiators
Brentwood Capital differentiates through: (1) deep vertical specialization in healthcare services and technology, with team members who are former operators and clinicians with intimate understanding of the sectors they serve; (2) institutional transaction experience combining rigorous process management with flexibility and speed; (3) strong, long-standing relationships with leading healthcare PE firms and strategic buyers cultivated over 25+ years; (4) Nashville-based advantage providing natural relationships with numerous healthcare platform companies and buyer headquarters in the region; (5) boutique independence allowing for faster decision-making and no conflicts of interest with corporate banking divisions or principal investment strategies; (6) breadth across both healthcare services and healthcare technology reducing single-vertical exposure; (7) experience in both platform acquisitions and add-on consolidations for financial sponsor clients; and (8) strong track record earning repeated mandates from existing client relationships and PE firm repeat work.
Not a Fit If
Brentwood Capital typically declines: businesses below $10-$15M TEV (outside their sweet spot), non-healthcare/non-healthcare technology companies outside the business services adjacencies, companies with significant outstanding litigation or regulatory issues, founders seeking limited buyer outreach processes (the firm's value is in exhaustive buyer identification), and highly distressed situations or turnarounds requiring operational restructuring support beyond financial advisory scope.
Team & Leadership
The firm employs approximately 28 professionals including 16 partners and 2 principals. Key leadership includes Tom Wylly (Chairman, 40+ years healthcare banking experience), L.A. Galyon IV (Managing Partner, 20+ years, 100+ completed transactions), John Allgood (Managing Director), Dan Beuerlein (Managing Director, 6+ years FINRA experience), Bryan Cloncs (Managing Director, FINRA registered), Burk Lindsey (Partner & Managing Director), Porter Meadors (Managing Director), and Michael Ory (Managing Director, FINRA registered). Director-level bankers include Patrick Price and Kyle Witty. The team's average partner experience exceeds 20 years in healthcare investment banking. Several team members are FINRA-registered (Series 79, Series 63 registrations), and the firm itself is FINRA member (CRD #118712) and SIPC member.
Geographic Coverage & Market Presence
Headquartered in Nashville, Tennessee (1600 West End Avenue Suite 1550), Brentwood Capital serves clients nationwide with deep market relationships in major metropolitan areas and regional healthcare clusters. The firm's Nashville headquarters provides natural competitive advantage for engaging healthcare platform companies and PE sponsors headquartered in the region (Whistler Capital Partners, Cressey & Company offices, and numerous healthcare operator headquarters).
Cultural Foundation
Bentwood's culture emphasizes principles of integrity, teamwork, transparency, mutual respect, accountability, family, and community. The firm was co-founded in 1999 by Tom Wylly and Kevin Murphy (who served as Managing Partner until his passing in 2020). Client testimonials consistently highlight the firm's dedication, strategic thinking, financial expertise, and willingness to provide candid, actionable advice throughout challenging transaction processes.